GlassScriptPhysician profile
Eldon Cameron Peters
NPI 1588071484
$1,548.05
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $45.96 · 2021: $63.18 · 2022: $225 · 2023: $211 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $214.62 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $161.29 | 2023 | |
| Globus Medical, INC. | $145.90 | 2025 | Senza |
| Horizon Therapeutics Plc | $138.05 | 2019-2022 | |
| Linvatec Corporation | $136.69 | 2025 | Rts, Neospan, Biobrace 23mm |
| In2bones USA, LLC | $134.24 | 2019 | |
| Organogenesis INC. | $133.87 | 2019-2022 | |
| Stryker Corporation | $113.55 | 2019 | |
| Grt US Holding, INC. | $80.25 | 2022 | |
| Djo, LLC | $77.13 | 2019 | |
| Paratek Pharmaceuticals, INC. | $50.00 | 2023 | Nuzyra |
| Melinta Therapeutics, LLC | $41.57 | 2019 | |
| Osteocentric Technologies, INC. | $37.85 | 2019 | |
| Acell, INC. | $24.74 | 2019 | |
| Triad Life Sciences INC. | $21.45 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $21.27 | 2019 | |
| Abbott Laboratories | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eldon Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.